7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

GlaxoSmithKline plc
(NYSE:GSK) 

GSK stock logo

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It op...

Founded: 2000
Full Time Employees: 99,437
Sector: Healthcare
Industry: Drug Manufacturers-General

Share this website to your friends
GlaxoSmithKline plc Number of Twitter Followers
202204 202205 202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 034.6969.38104.08138.77173.46208.15242.84Thousand
GlaxoSmithKline plc Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 097.37194.73292.1389.46486.83584.2681.56
GlaxoSmithKline plc Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 013.3426.6840.0153.3566.6980.0393.37
GlaxoSmithKline plc Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 034.0868.16102.23136.31170.39204.47238.55
GlaxoSmithKline plc Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.931.862.83.734.665.596.53
GlaxoSmithKline plc Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.671.342.012.683.364.034.7
GlaxoSmithKline plc Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.581.161.742.322.93.484.06
GlaxoSmithKline plc P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.320.630.951.271.591.92.22
GlaxoSmithKline plc (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.967.9311.8915.8519.8123.7827.74
GlaxoSmithKline plc P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.462.934.395.857.328.7810.24
No extra charts and metrics for this ticker.